Published by Frank Prenesti on 2nd December 2022
(Sharecast News) - GSK on Friday unveiled positive headline results from a Phase 3 trial of its Jemperli endometrial cancer drug.
URL: http://www.digitallook.com/dl/news/story/33150717/...